Ginkgo Bioworks
DNA
DNA
166 hedge funds and large institutions have $183M invested in Ginkgo Bioworks in 2025 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 49 increasing their positions, 31 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
166
Holders Change
+1
Holders Change %
+0.61%
% of All Funds
2.26%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
33
Increased
49
Reduced
31
Closed
28
Calls
$5.98M
Puts
$3.76M
Net Calls
+$2.22M
Net Calls Change
-$19.8M
Top Buyers
| 1 |
EAM
Erste Asset Management
Vienna,
Austria
|
+$5.19M |
| 2 |
Millennium Management
New York
|
+$4.32M |
| 3 |
Legal & General Group
London,
United Kingdom
|
+$3.23M |
| 4 |
JMFC
J.M. Forbes & Co
Boston,
Massachusetts
|
+$2.24M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$1.51M |
Top Sellers
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$15.7M |
| 2 |
D.E. Shaw & Co
New York
|
-$5.37M |
| 3 |
CBA
Coastal Bridge Advisors
Westport,
Connecticut
|
-$2.72M |
| 4 |
Walleye Capital
New York
|
-$2.61M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$2.33M |
